The widespread availability of free multidrug therapy for leprosy has reduced the global burden of disease by 99 percent since the late 1980s. However, between 2008 and 2017, the number of newly diagnosed leprosy patients stagnated at about 200,000 people per year, until in 2018 the number fell to 184,212.